MAP2K7 and breast cancer: Our previous studies demonstrated that CYT-Rx20 (3′-hydroxy-4′-methoxy-β- methyl-β-nitrostyrene), a synthetic derivative of β-nitrostyrene, tended to increase the anti-platelet activity and induces breast cancer cell death and autophagy through ROS-mediated MEK/ERK pathway [10,18].